Atorvastatin Calcium
Product Images NDC 43353-904

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-904). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure- Atorvastatin Calcium (42571de8 Acc9 42ef 89b7 08b9a91e3fbd 01)

Chemical structure of atorvastatin calcium, showing the detailed molecular arrangement including aromatic rings, hydroxyl groups, and associated calcium ion with a co-crystallized organic acid.*

FDA Label Image

Figure 1 (42571de8 Acc9 42ef 89b7 08b9a91e3fbd 02)

A line graph comparing cumulative incidence (%) over 3.5 years between Atorvastatin and Placebo groups. The solid line represents Atorvastatin, showing lower cumulative incidence compared to the dashed Placebo line. The graph includes a hazard ratio (HR=0.64) and p-value (0.0005) indicating statistical analysis.*

FDA Label Image

Figure 2 (42571de8 Acc9 42ef 89b7 08b9a91e3fbd 03)

A cumulative hazard curve comparing Placebo and Atorvastatin over a follow-up period of up to four years. The graph shows the time to first primary endpoint with cumulative hazard percentage on the vertical axis and years on the horizontal axis. The Placebo group is represented by a dashed line, and the Atorvastatin group by a solid line, with hazard ratio and p-value noted on the chart.*

FDA Label Image

Figure 3 (42571de8 Acc9 42ef 89b7 08b9a91e3fbd 04)

A line graph showing the percentage of subjects experiencing a first major cardiovascular event over five years, comparing Atorvastatin 10 mg and 80 mg doses. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes hazard ratio and p-value statistics.*

FDA Label Image

Bottle Label 80mg (43353 815 15)

Atorvastatin Calcium 80 mg tablet label showing a package of 15 tablets. The label includes manufacturer information for Apotex Inc., Toronto, Canada, and repackager Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN. It specifies storage instructions, lot number, expiration date, and indicates prescription use only.*

FDA Label Image

Bottle Label 40mg (43353 821 15)

Label for Atorvastatin Calcium 40 mg tablets, containing 15 tablets per package. The label includes storage instructions, repackaging information by Aphena Pharma Solutions - Tennessee, LLC, and is marked for prescription use only. The manufacturer is listed as Apotex Inc., Toronto, Canada.*

FDA Label Image

Bottle Label 20mg (43353 904 45)

Label for Atorvastatin Calcium 20mg tablets, containing 45 tablets per bottle. The label includes storage instructions, manufacturer information indicating Apotex Inc. as the original manufacturer, with repackaging by Aphena Pharma Solutions - Tennessee, LLC. The label also displays an NDC number and states RX Only.*

FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.